Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02612493
NCT02612493
Completed
Not Applicable

Obesity and Metabolic Surgery in Patients With Type I Diabetes

Sana Klinikum Offenbach0 sites16 target enrollmentJanuary 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType I Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type I Diabetes
Sponsor
Sana Klinikum Offenbach
Enrollment
16
Primary Endpoint
Insulin dosage
Status
Completed
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Obesity is the indication for bariatric surgery in type I diabetes. Interestingly postsurgery the patients improve remarkable in their need for insulin, not only in the daily total insulin dosage but also in the dosage of IU per kg.

Detailed Description

The investigators performed a retrospective analysis on 16 patients undergoing weight loss surgery in obesity with concomitant type I diabetes. All patients were evaluated during Follow - Up to analyze insulin dosage and metabolic changes.

Registry
clinicaltrials.gov
Start Date
January 2006
End Date
November 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sana Klinikum Offenbach
Responsible Party
Principal Investigator
Principal Investigator

Christine Stier

MD, PhD

Sana Klinikum Offenbach

Eligibility Criteria

Inclusion Criteria

  • •type I diabetes
  • •BMI \> 40kg/m2

Exclusion Criteria

  • •type II diabetes

Outcomes

Primary Outcomes

Insulin dosage

Time Frame: up to 8 years

Insulin dosage postsurgery

Secondary Outcomes

  • Change in lipids(up to 8 years)
  • Excess Weight loss in %(up to 8 years)
  • Change in HgA1c(up to 8 years)

Similar Trials

Recruiting
Not Applicable
Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 DiabetesDiabetes Mellitus, Type 2Obesity
NCT06600555Médipôle Lyon-Villeurbanne30
Completed
Not Applicable
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous InfusionType 2 Diabetes Mellitus
NCT03223129Catholic University of the Sacred Heart23
Completed
Not Applicable
Laparoscopic Gastric Bypass as Metabolic Surgery in Obesity Class 1Type2 DiabetesBariatric Surgery CandidateLaparoscopic Gastric BypassObesity
NCT04595396CARLOS ZERRWECK LOPEZ51
Unknown
Not Applicable
The Metabolic Impact of Bariatric Surgery Compared to Best Diabetic Care on Manitoba's Urban Indigenous PopulationType2 Diabetes MellitusObesityBariatric Surgery Candidate
NCT03301545University of Manitoba60
Completed
Not Applicable
An Analysis of Lipid and Glucose Metabolism Following Bariatric SurgeryMorbid Obesity
NCT02067585University of Alberta48